Abstract:ImportanceInterstitial cystitis (IC) is a debilitating condition. Although viral infection is a potential etiological cause, few studies have detected the effect of antiviral treatment.ObjectiveTo determine the efficacy and safety of intravesical interferon instillation compared with hyaluronic acid in female patients with IC.Design, Setting, and ParticipantsThis double-masked, randomized phase 2/3 clinical trial with parallel group design was implemented from October 2022 to April 2023 and had a 6-month follow-up period. The study was conducted at a single center. Eligible participants were female patients aged 18 to 70 years with a diagnosis of IC for more than 6 months. The last visit took place in October 2023. Data were analyzed between October and November 2023.InterventionPatients were randomized 1:1 to receive either intravesical instillation of interferon or hyaluronic acid.Main Outcomes and MeasuresThe primary end point was change in visual analog scale pain score. Secondary end points included changes in voiding frequency, functional bladder capacity, symptom index, and global response assessment. Adverse events were closely monitored.ResultsAmong the 52 patients, the mean (SD) age was 50.0 (14.1) years and they were randomized to either the interferon group (26 [50%]) or hyaluronic acid (26 [50%]). The visual analog pain score showed the interferon group decreased more significantly than hyaluronic acid (−1.3; 95% CI, −2.3 to −0.3; P = .02) at month 6, with 20 patients (77%) exhibiting a 30% or higher reduction in pain compared with baseline. Secondary end points of voiding frequency, functional bladder capacity, and nocturia episodes showed no significant difference between 2 therapies. However, interferon showed a significantly higher reduction in the Interstitial Cystitis Symptom Index (−3.0; 95% CI, −5.3 to −0.7; P = .01) and the Problem Index (−2.5; 95% CI, −4.5 to −0.4; P = .02) at month 6, with 22 patients (85%) presenting as moderately or markedly improved. The frequencies of adverse events were similar between 2 groups. Only 1 patient discontinued hyaluronic acid because of poor effectiveness.Conclusions and RelevanceIn this randomized clinical trial, female patients with IC could benefit from intravesical interferon therapy, without serious adverse events. These results offered hope for antiviral approaches in IC, but larger-scale, multicenter trials and long-term follow-up should be considered.Trial RegistrationClinicalTrials.gov Identifier: NCT05912946

Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary–Sant symptom index

Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials

Efficacy assessment of bladder hydrodistension combined with drug intravesical instilla-tion for treatment of interstitial cystitis/bladder pain syndrome

Resiniferatoxin in the Treatment of Interstitial Cystitis

Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study

Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review

Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life

Intravesical instillation resiniferatoxin and hydrodistention for the treatment of interstitial cystitis

Feasibility of Ultrasound-Guided Peritoneal Perfusion with Ozone in the Treatment of Chronic Pelvic Pain: A Bicenter Retrospective Analysis

Efficacy and Safety Comparison of Pharmacotherapies for Interstitial Cystitis and Bladder Pain Syndrome: a Systematic Review and Bayesian Network Meta-Analysis

Effects of onabotulinum toxin‐A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study

A Clinical Trial of Ozone in the Treatment of Vulvovaginal Candidiasis

Intravesical Interferon Therapy Vs Hyaluronic Acid for Pain among Female Individuals with Interstitial Cystitis

The therapy effect of amitriptyline and dimethyl sulfoxide for interstitial cystitis—a clinical research

Effects of Ozone Disc Nucleolysis in Management of Herniated Lumbar Intervertebral Disc: A Retrospective Single-Center Study of 149 Patients

Clinical evaluation on therapeutic effect of vulvovaginal candidiasis with ozone

[Efficiency of O'Leary-Sant Symptom Index and Problem Index in the Diagnosis of Interstitial Cystitis].

Efficacy Comparison of Interstitial Cystitis/painful Bladder Syndrome Patients Treated with Four-Drug Combination and Sodium Hyaluronate Intravesical Instillation

Clinical Efficacy of Submucosal Injection of Triamcinolone Acetonide in the Treatment of Type II/III Interstitial Cystitis/bladder Pain Syndrome

[The Study of Diagnosis and Treatment of Interstitial Cystitis].

Intravesical Hyaluronic Acid and Alkalinized Lidocaine for the Treatment of Severe Painful Bladder Syndrome/interstitial Cystitis